Cancer Epidemiology Cohort in Male Health Professionals
Cancer Epidemiology Cohort in Male Health Professionals
批准号:
9242751
负责人:
Lorelei Mucci
金额:
$188.44万
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-08-21 至 2022-07-31
关键词:
AccelerometerAgeArchivesBiologicalBloodCancer BurdenCancer EtiologyCancer PatientCessation of lifeCohort StudiesCollaborationsCollectionColonColorectal CancerCommon NeoplasmCommunitiesDNADataData AdjustmentsDatabasesDiagnosisDiagnosticDietDietary AssessmentDietary FactorsDisease ProgressionErythrocytesFactor AnalysisFollow-Up StudiesFoodFrequenciesFundingFutureGoalsHealthHealth ProfessionalImageIncidenceLaboratoriesLightMalignant NeoplasmsMalignant neoplasm of lungMalignant neoplasm of prostateMedicare claimMethodsMolecular EpidemiologyMorbidity - disease rateNucleic AcidsNurses&apos Health StudyOutcomeOutpatientsPaperParticipantPathologicPharmaceutical PreparationsPharmacotherapyPhasePhysical activityPilot ProjectsPlasmaPositioning AttributePrevention strategyPrimary PreventionProcessProstatePublicationsPublishingQuality of lifeQuestionnairesResearch ActivityResearch InfrastructureResearch PersonnelResource SharingResourcesRisk FactorsRunningSamplingSecondary PreventionSeminal fluidSmokeSmokingSpecimenStructure of nail of toeSupport SystemSystemSystems AnalysisTimeTissue BanksTissue MicroarrayTissuesTumor TissueUpdateWeightWomanbiobankcancer diagnosiscancer epidemiologycancer riskcancer survivalcancer therapycohortcostdata managementdoubly-labeled waterearly detection biomarkersepidemiology studyfollow-upgenetic epidemiologyhealth care service utilizationindexinginnovationmale healthmembermenmortalitynon-smokernovelprospectiverepositorysexvalidation studiesvirtual
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY
The goal of this competing renewal application is to support the core infrastructure and continued follow-up of
the Health Professionals Follow-up Study (HPFS), a cancer epidemiology cohort (CEC) established in 1986
and including 51,529 male health professionals age 40 to 75 years at baseline. This cohort is unique in its
focus on men's health and follow-up of almost three decades, a time frame that is essential to realistically
understand the relation between modifiable factors and cancer risk. Over this period of time, data has been
regularly updated on diet, activity, smoking, weight, medications, and other potentially modifiable determinants
of cancer risk. An extensive biorepository has been established that includes DNA from most participants,
toenails, red cells, and plasma. Tumor tissue has been obtained from a high percentage of incident prostate
and colorectal cancers; a recent supplement is supporting collection of tissue for less common tumors and
noncancerous prostate tissue. Cohort follow-up has been consistently 90% or higher at each two-year cycle
and mortality follow-up is virtually complete. Epidemiological studies from the HPFS, alone and through
participation in consortia, have helped elucidate risk factors for cancer incidence and determinants of cancer
survival in men. With cohort members now in an age of high cancer incidence, the HPFS is in a highly
productive phase. During the current funding cycle, 325 papers have been published that utilize data and/or
biological samples from HPFS; 200 of these have specifically examined cancer or cancer precursor outcomes.
To date, 13,346 participants have been diagnosed with cancer and 3,571 cancer deaths have occurred; 5,791
men in HPFS are currently living with a cancer diagnosis. In the next funding cycle, we propose the following
aims. 1-) To continue active follow-up for cancer incidence and mortality and to update exposure data pre and
post-diagnosis of cancer. 2-) To update the food composition database that supports dietary assessment in
HPFS and the Nurses' Health Study I and II cohorts. 3-) To leverage a recently completed validation study of
physical activity and collaborate with colleagues in two multiethnic cohorts of men to calibrate physical activity
questions. 4-) To make a first time linkage to Medicare Claims data. 5-) To maintain the HPFS cancer tissue
biorepository, and expand collections of prostate and colon, and undertake a new collection of lung cancer in
nonsmokers. 6-) To maintain the other biorepositories including plasma, red blood cells, germline DNA, and
toenail samples. 7-) To undertake a new post-diagnostic blood collection among men with prostate cancer. 8-)
To maintain and augment the statistical infrastructure and data management of the cohort. 9-) To facilitate
resource sharing and collaborations with other CECs and outside investigators. With additional cohort follow-
up, particularly after cancer diagnosis, the HPFS remains ideally positioned to make innovative contributions to
our overall goal of reducing the burden of cancer by identifying primary and secondary prevention strategies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Cancer Epidemiology Cohort in Male Health Professionals
-
批准号:10273315
-
项目类别:
-
资助金额:$15.95万
-
财政年份:2021
-
负责人:Lorelei Mucci
-
依托单位:
Circadian Disruption and Risk of Prostate Cancer in a Multiethnic Cohort
-
批准号:9017298
-
项目类别:
-
资助金额:$29.97万
-
财政年份:2016
-
负责人:Lorelei Mucci
-
依托单位:
Integrative Molecular Epidemiology Workshop
-
批准号:10013130
-
项目类别:
-
资助金额:$13.1万
-
财政年份:2013
-
负责人:Lorelei Mucci
-
依托单位:
Integrative Molecular Epidemiology Workshop
-
批准号:10477181
-
项目类别:
-
资助金额:$11.4万
-
财政年份:2013
-
负责人:Lorelei Mucci
-
依托单位:
Integrative Molecular Epidemiology Workshop
-
批准号:10673025
-
项目类别:
-
资助金额:$25.84万
-
财政年份:2013
-
负责人:Lorelei Mucci
-
依托单位:
Cancer Epidemiology Cohort in Male Health Professionals
-
批准号:10387375
-
项目类别:
-
资助金额:$146.99万
-
财政年份:2012
-
负责人:Lorelei Mucci
-
依托单位:
Cancer Epidemiology Cohort in Male Health Professionals
-
批准号:9750056
-
项目类别:
-
资助金额:$188.36万
-
财政年份:2012
-
负责人:Lorelei Mucci
-
依托单位:
Cancer Epidemiology Cohort in Male Health Professionals
-
批准号:10224870
-
项目类别:
-
资助金额:$178.22万
-
财政年份:2012
-
负责人:Lorelei Mucci
-
依托单位:
Cancer Epidemiology Cohort in Male Health Professionals
-
批准号:10625288
-
项目类别:
-
资助金额:$141.79万
-
财政年份:2012
-
负责人:Lorelei Mucci
-
依托单位:
Sex-Hormones and the TMPRSS2: ERG Fusion in Prostate Cancer Progression
-
批准号:8433476
-
项目类别:
-
资助金额:$31.57万
-
财政年份:2009
-
负责人:Lorelei Mucci
-
依托单位:
Sex-Hormones and the TMPRSS2: ERG Fusion in Prostate Cancer Progression
-
批准号:8014969
-
项目类别:
-
资助金额:$33.88万
-
财政年份:2009
-
负责人:Lorelei Mucci
-
依托单位:
Sex-Hormones and the TMPRSS2: ERG Fusion in Prostate Cancer Progression
-
批准号:7564215
-
项目类别:
-
资助金额:$38.07万
-
财政年份:2009
-
负责人:Lorelei Mucci
-
依托单位:
Sex-Hormones and the TMPRSS2: ERG Fusion in Prostate Cancer Progression
-
批准号:8210940
-
项目类别:
-
资助金额:$33.71万
-
财政年份:2009
-
负责人:Lorelei Mucci
-
依托单位:
Tumor and Circulating Markers as Links Between Obesity and Lethal Prostate Cance
-
批准号:8764821
-
项目类别:
-
资助金额:$39.42万
-
财政年份:2002
-
负责人:Lorelei Mucci
-
依托单位:
Tumor and Circulating Markers as Links Between Obesity and Lethal Prostate Cance
-
批准号:9313623
-
项目类别:
-
资助金额:$36.01万
-
财政年份:2002
-
负责人:Lorelei Mucci
-
依托单位:
Tumor and Circulating Markers as Links Between Obesity and Lethal Prostate Cance
-
批准号:8554551
-
项目类别:
-
资助金额:$30.44万
-
财政年份:2002
-
负责人:Lorelei Mucci
-
依托单位:
Program 7: Cancer Epidemiology
-
批准号:10062923
-
项目类别:
-
资助金额:$6.82万
-
财政年份:1997
-
负责人:Lorelei Mucci
-
依托单位:
Program 07 Cancer Epidemiology
-
批准号:10540370
-
项目类别:
-
资助金额:$4.04万
-
财政年份:1997
-
负责人:Lorelei Mucci
-
依托单位:
Program 07 Cancer Epidemiology
-
批准号:10332551
-
项目类别:
-
资助金额:$4.04万
-
财政年份:1997
-
负责人:Lorelei Mucci
-
依托单位:
Program 7: Cancer Epidemiology
-
批准号:10004865
-
项目类别:
-
资助金额:$0.62万
-
财政年份:--
-
负责人:Lorelei Mucci
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: